Description for CJC-1295 With DAC 5mg Peptide.

Tesamorelin 10mg Peptide – The Long-Acting GHRH Analog Designed for Sustained GH Pulse Amplification

What if a single engineered peptide could lock onto the pituitary GHRH receptor and keep it signaling for days—delivering sustained, physiological pulses of growth hormone, elevating IGF-1 steadily within youthful ranges, selectively mobilizing visceral fat in metabolic models, and providing researchers with a powerful window into prolonged somatotropic axis activation without the rollercoaster spikes of short-acting agents or direct GH? This is the breakthrough capability driving intense interest in Tesamorelin 10mg Peptide, the modified GHRH(1-44) analog that has become a cornerstone compound in metabolic, endocrine, and lipodystrophy research.

At Cali BioLab Peptides, Tesamorelin 10mg Peptide is supplied as a high-purity (≥99%), sterile lyophilized powder in a 10mg vial—third-party HPLC/MS verified, with batch-specific COAs and fast USA domestic shipping. Perfect for investigating extended GH release kinetics, visceral adipose tissue dynamics, and age- or disease-related GH/IGF-1 axis modulation.

Strict Disclaimer: For laboratory and scientific research use only. Not for human consumption, therapeutic, diagnostic, veterinary, or any non-research application. Strictly intended for qualified researchers conducting in-vitro, ex-vivo, or ethically approved animal model studies. Cali BioLab Peptides maintains full regulatory compliance.

Scientific Identifiers for Tesamorelin 10mg Peptide

• Full Chemical Name: Tesamorelin acetate (trans-3-hexenoyl-[D-Tyr¹]-GHRH(1-44) amide)
• CAS Number: 901758-09-6 (free base form)
• Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S (free base)
• Molecular Weight: ≈5135.9 Da (free base); ~5196 Da (acetate salt)
• Sequence: 44-amino-acid chain with N-terminal trans-3-hexenoyl modification and C-terminal amidation
• EC Number: Not assigned (research peptide)
• Purity: ≥99% (HPLC/MS verified)
• Appearance: White to off-white lyophilized powder

These identifiers confirm Tesamorelin 10mg Peptide as a precisely modified, long-acting GHRH analog engineered for extended receptor activation.

What Is Tesamorelin 10mg Peptide and How Does It Work?

Tesamorelin 10mg Peptide is a synthetic analog of human growth hormone-releasing hormone (hGHRH 1-44), modified with an N-terminal trans-3-hexenoyl group for increased stability and resistance to DPP-IV cleavage, and C-terminal amidation for enhanced receptor affinity and duration.

The "how" of Tesamorelin 10mg Peptide is highly specific: it binds the pituitary GHRH receptor (GHRHR) → activates Gs → elevates cAMP → triggers pulsatile GH exocytosis from somatotrophs. The DAC-like modification (though not true DAC) extends half-life to ~5–8 days in models, producing sustained, dose-dependent GH pulses and prolonged IGF-1 elevation without desensitization in short-term protocols.

Unlike short-acting GHRH or direct GH, Tesamorelin 10mg Peptide preserves natural feedback loops, avoids supraphysiological IGF-1 peaks, and selectively favors visceral lipolysis over systemic effects in many models.

Here are professional examples of Tesamorelin 10mg Peptide research-grade lyophilized vials in sterile glass packaging, showcasing the clean, high-quality presentation typical for lab use:

Usage and Reconstitution Guidelines for Tesamorelin 10mg Peptide

Proper handling preserves Tesamorelin 10mg Peptide bioactivity:

1. Allow vial to reach room temperature.
2. Add 1–2 mL bacteriostatic water or sterile PBS; gently swirl (avoid shaking).
3. Prepare stock solutions (e.g., 5 mg/mL) and dilute for working concentrations (typically 0.1–2 mg/kg in vivo or μg/mL in vitro).
4. Aliquot immediately and store at –80 °C; thawed aliquots stable 2–8 °C for days.

Common research routes: subcutaneous injection (most frequent in animal models), intravenous, or localized delivery. Use sterile technique.

Research Applications of Tesamorelin 10mg Peptide

Tesamorelin 10mg Peptide is widely applied in:

• Pulsatile GH secretion profiling (serial sampling, GH pulse analysis)
• Visceral adipose tissue reduction in lipodystrophy, obesity, or metabolic syndrome analogs
• IGF-1 mediated metabolic effects (lipolysis, insulin sensitivity, lipid profiles)
• Age-related GH/IGF-1 axis decline and endocrine rejuvenation models
• Synergy studies with GHRPs (Ipamorelin, GHRP-6) for amplified GH release
• Liver lipid handling and NAFLD models

Key research endpoints where Tesamorelin 10mg Peptide excels:

• Reduction in visceral fat volume (DEXA, MRI, CT quantification)
• Normalization of GH pulse amplitude and frequency
• Improvement in insulin sensitivity and lipid metabolism
• Preservation or enhancement of lean mass in catabolic models
• Modulation of hepatic steatosis and inflammatory markers

These applications make Tesamorelin 10mg Peptide a preferred probe for GHRH-mediated metabolic and endocrine research.

Frequently Asked Questions About Tesamorelin 10mg Peptide

Q: How does Tesamorelin 10mg Peptide differ from CJC-1295 with DAC? A: Both are long-acting GHRH analogs, but Tesamorelin 10mg Peptide is clinically optimized for visceral fat selectivity in lipodystrophy models, with a specific modification profile; CJC-1295 DAC often features a true Drug Affinity Complex for even longer half-life.

Q: What dosing is typical in preclinical animal models? A: Studies often use 0.1–2 mg/kg subcutaneous daily or every few days; adjust based on species, duration, and endpoint.

Q: Is Tesamorelin 10mg Peptide stable after reconstitution? A: Yes—stable for weeks refrigerated when aliquoted; freeze for longer storage.

Q: Can Tesamorelin 10mg Peptide be combined with GHRP secretagogues? A: Yes—GHRH + GHRP synergy is extensively documented for amplified, pulsatile GH release.

Q: How to verify batch purity? A: Cross-reference the provided COA on the product page at calibiolabpeptides.com.

One Question That Could Shape Your Next GH Axis Study

If you could precisely sustain physiological GH pulses for days in an aging or metabolically dysregulated model right now, which endpoint—visceral fat mobilization, IGF-1 normalization, insulin sensitivity, or lean mass preservation—would you prioritize first, and why?

Your answer might define your next major publication.

In summary, Tesamorelin 10mg Peptide from Cali BioLab Peptides is a long-acting, selective GHRH analog for studying sustained somatotropic and metabolic effects. With exceptional purity, reliable supply, and proven utility in lipodystrophy, obesity, and endocrine models, it's ready to advance your 2026 research.

Order your Tesamorelin 10mg Peptide today at Cali BioLab Peptides and investigate prolonged GH dynamics with precision and confidence.